Table 2 Multivariable analysis for the risk of dying from acute lymphoblastic leukaemia for patients aged < 18 years in the Netherlands between 1990 and 2015.
N | HRa | 95% CI | P value | |
|---|---|---|---|---|
Period | ||||
1990–94 | 481 | Ref. | ||
1995–99 | 589 | 0.9 | 0.7–1.2 | 0.56 |
2000–04 | 640 | 0.7 | 0.5–0.9 | 0.01 |
2005–09 | 585 | 0.5 | 0.1–0.3 | <0.01 |
2010–15 | 702 | 0.4 | 0.1–0.3 | <0.01 |
Sex | ||||
Male | 1744 | Ref. | ||
Female | 1253 | 0.9 | 0.7–1.1 | 0.19 |
Age groups (years) | ||||
0 | 90 | 8.2 | 5.8–12 | <0.01 |
1–4 | 1385 | Ref. | ||
5–9 | 796 | 1 | 0.8–1.4 | 0.79 |
10–14 | 479 | 2.1 | 1.6–2.8 | <0.01 |
15–17 | 247 | 3.5 | 2.6–4.7 | <0.01 |
Immunophenotype | ||||
BCP-ALL | 2562 | Ref. | ||
T-cell ALL | 424 | 1.9 | 1.5–2.4 | <0.01 |
Unknown | 11 | ND | ||